1. Home
  2. RIG vs SRPT Comparison

RIG vs SRPT Comparison

Compare RIG & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIG
  • SRPT
  • Stock Information
  • Founded
  • RIG 1926
  • SRPT 1980
  • Country
  • RIG Switzerland
  • SRPT United States
  • Employees
  • RIG N/A
  • SRPT N/A
  • Industry
  • RIG Oil & Gas Production
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RIG Energy
  • SRPT Health Care
  • Exchange
  • RIG Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • RIG N/A
  • SRPT N/A
  • IPO Year
  • RIG 1993
  • SRPT 1997
  • Fundamental
  • Price
  • RIG $2.60
  • SRPT $39.31
  • Analyst Decision
  • RIG Hold
  • SRPT Buy
  • Analyst Count
  • RIG 8
  • SRPT 23
  • Target Price
  • RIG $4.36
  • SRPT $131.09
  • AVG Volume (30 Days)
  • RIG 40.6M
  • SRPT 3.8M
  • Earning Date
  • RIG 04-28-2025
  • SRPT 05-06-2025
  • Dividend Yield
  • RIG N/A
  • SRPT N/A
  • EPS Growth
  • RIG N/A
  • SRPT N/A
  • EPS
  • RIG N/A
  • SRPT N/A
  • Revenue
  • RIG $3,667,000,000.00
  • SRPT $2,233,371,000.00
  • Revenue This Year
  • RIG $10.24
  • SRPT $64.51
  • Revenue Next Year
  • RIG $2.91
  • SRPT $22.40
  • P/E Ratio
  • RIG N/A
  • SRPT N/A
  • Revenue Growth
  • RIG 24.47
  • SRPT 59.15
  • 52 Week Low
  • RIG $1.97
  • SRPT $35.46
  • 52 Week High
  • RIG $6.38
  • SRPT $173.25
  • Technical
  • Relative Strength Index (RSI)
  • RIG 55.54
  • SRPT 27.67
  • Support Level
  • RIG $2.27
  • SRPT $35.46
  • Resistance Level
  • RIG $2.45
  • SRPT $64.80
  • Average True Range (ATR)
  • RIG 0.13
  • SRPT 3.68
  • MACD
  • RIG 0.07
  • SRPT -1.45
  • Stochastic Oscillator
  • RIG 98.08
  • SRPT 13.12

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: